Effect of testosterone on blood-clotting markers in transsexual men
Hematology, Transfusion and Cell Therapy · 2025-07 · 47 (3) · 103862
DOI: 10.1016/j.htct.2025.103862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2025-07. Verfasst von Estella Thaisa Sontag Dos Reis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Universidade de São Paulo.
Abstract (Originalsprache)
Background
The use of testosterone in gender-affirming hormone therapy for trans men is associated with several adverse effects. However, research on the risk of venous thromboembolism in this treatment remains limited and inconclusive. This study aimed to assess the impact of intramuscular testosterone on specific direct and indirect blood-clotting markers in trans men.
Method
Treatment of trans men without previous use of testosterone was followed up in a prospective observational study in a trans people healthcare service. Gender-affirming hormone therapy was initiated with intramuscular testosterone cypionate (Depo-Testosterone). The blood-clotting markers prothrombin time, activated partial thromboplastin time, d-dimer, antithrombin, and factors VIII and VII were evaluated before and 12 weeks after starting the medication.
Results
Nineteen trans men with a mean age of 23.7 ± 3.7 years were enrolled. After 12 weeks of hormone therapy, significant increases in weight (p-value = 0.002) and body mass index (p-value = 0.007) were observed in patients. Furthermore, there were significant increases of 830 % in serum testosterone (p-value = 0.000), 7 % in hemoglobin (p-value = 0.000) and 10 % in hematocrit (p-value = 0.001). Conversely, a 10 % decrease in high density lipoprotein cholesterol levels (p-value = 0.000), and 15 % decrease in Factor VII (p-value = 0.000) were detected.
Conclusion
Intramuscular testosterone in trans men was associated with increases in hematocrit, hemoglobin, and the body mass index, and decreases in high density lipoprotein cholesterol and Factor VII. Nevertheless, these variables remained within normal reference values. Long-term follow-up studies evaluating gender-affirming hormone therapy with testosterone are needed to determine adequate risk management of venous and arterial thromboembolism in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil.
- Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil. Electronic address: carla_mfd@hotmail.com.
Förderung
- Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Universidade de São Paulo
Zitieren
APA
Sontag Dos Reis, E. T., Dias, C. M. F., Vieira, C. S., Nadai, M. N., Okano, S. H. P., Franceschini, S. A., & Lara, L. A. D. S. (2025). Effect of testosterone on blood-clotting markers in transsexual men. Hematology, Transfusion and Cell Therapy, 47(3), 103862. https://doi.org/10.1016/j.htct.2025.103862
Vancouver
Sontag Dos Reis ET, Dias CMF, Vieira CS, Nadai MN, Okano SHP, Franceschini SA, et al. Effect of testosterone on blood-clotting markers in transsexual men. Hematology, Transfusion and Cell Therapy. 2025;47(3):103862. doi:10.1016/j.htct.2025.103862
BibTeX
@article{SontagDosReis2025,
author = {Sontag Dos Reis, Estella Thaisa and Dias, Carla Maria Franco and Vieira, Carolina Sales and Nadai, Mariane Nunes and Okano, Sérgio Henrique Pires and Franceschini, Silvio Antônio and Lara, Lúcia Alves da Silva},
title = {Effect of testosterone on blood-clotting markers in transsexual men},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2025},
volume = {47},
number = {3},
pages = {103862},
doi = {10.1016/j.htct.2025.103862}
}
EUVIMED